Vaccines, Blood & Biologics
-
Concluding Review Memo/E-mail for Rota CMC
| From: | Feigelstock, Dino |
| Sent: | Wednesday, April 02, 2008 12:12 PM |
| To: | Henchal, Laraine; Levis, Robin |
| Cc: | Feinstone, Stephen; Krause, Philip; Vujcic, Luba; Weir, Jerry P. |
| Subject: | concluding review memo/e-mail for Rota CMC |
Laraine;
Upon further discussion and review of the --------------- step and the in process controls to measure product quality after ---------------, it has been concluded that GSK's use of the - --------- is appropriate and there are no remaining issues regarding this step in manufacturing.
Dino
-
-







